Login to Your Account



After Acquisition, Genzyme's Partners Wonder What's Next

By Tom Wall


Friday, February 18, 2011
Sanofi-Aventis SA's $20.1 billion acquisition of Genzyme Corp. has a number of Genzyme partners, analysts and investors wondering what happens next.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription